Search research articles
Contact Us
Filters
Showing results (11-20 of 62) with videos related to
Page
of 7
Sort By:
Transplantation Proceedings
|
June 1, 1978
Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients
T C Fuller, A B Cosimi, P S Russell
Clinical Transplants
|
January 1, 1990
1,000 renal transplants at the Massachusetts General Hospital: improved allograft survival for high-risk patients without regard to HLA matching
F L Delmonico, T C Fuller, A B Cosimi
Transplantation
|
September 10, 1999
Repeat donor HLA-DR mismatches in renal transplantation: is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies?
A Fuller, T Profaizer, L Roberts, et al.
Human Immunology
|
January 1, 1983
Direct estimation of the frequency of human cytotoxic T lymphocytes and their precursors following in vitro allosensitization
D J Bryan, C E Pinto, T C Fuller
Tissue Antigens
|
November 1, 1995
Identification of a new HLA-DR3 allele: DRB1*0305
U M Asu, M Taylor, D Dunn, et al.
The American Journal of Psychiatry
|
February 1, 1983
Panic disorder in genotypic HLA identical sibling pairs
O S Surman, D V Sheehan, T C Fuller, et al.
Human Immunology
|
July 1, 1990
Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes
A A Fuller, G E Rodey, P Parham, et al.
Transplantation
|
April 15, 1996
In support of the findings of Christopher F. Bryan et al
T C Fuller, A Fuller, J M McCormack, et al.
Transplantation
|
July 1, 1982
Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test
T C Fuller, D Phelan, H M Gebel, et al.
Human Immunology
|
August 1, 1997
HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure
T C Fuller, A A Fuller, M Golden, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 62) with videos related to
Sort By:
Page
of 7
Transplantation Proceedings
|
June 1, 1978
Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients
T C Fuller, A B Cosimi, P S Russell
Clinical Transplants
|
January 1, 1990
1,000 renal transplants at the Massachusetts General Hospital: improved allograft survival for high-risk patients without regard to HLA matching
F L Delmonico, T C Fuller, A B Cosimi
Transplantation
|
September 10, 1999
Repeat donor HLA-DR mismatches in renal transplantation: is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies?
A Fuller, T Profaizer, L Roberts, et al.
Human Immunology
|
January 1, 1983
Direct estimation of the frequency of human cytotoxic T lymphocytes and their precursors following in vitro allosensitization
D J Bryan, C E Pinto, T C Fuller
Tissue Antigens
|
November 1, 1995
Identification of a new HLA-DR3 allele: DRB1*0305
U M Asu, M Taylor, D Dunn, et al.
The American Journal of Psychiatry
|
February 1, 1983
Panic disorder in genotypic HLA identical sibling pairs
O S Surman, D V Sheehan, T C Fuller, et al.
Human Immunology
|
July 1, 1990
Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes
A A Fuller, G E Rodey, P Parham, et al.
Transplantation
|
April 15, 1996
In support of the findings of Christopher F. Bryan et al
T C Fuller, A Fuller, J M McCormack, et al.
Transplantation
|
July 1, 1982
Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test
T C Fuller, D Phelan, H M Gebel, et al.
Human Immunology
|
August 1, 1997
HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure
T C Fuller, A A Fuller, M Golden, et al.
Page
of 7